Press Releases

November 20, 2024 Regulatory

PMD Device Solutions Announces Delay to Q3 2024 Quarterly Report

November 5, 2024 Regulatory

PMDS announces last day of trading in BTA

October 29, 2024 Regulatory

Bulletin from the extraordinary general meeting in PMD Device Solutions AB (publ)

October 29, 2024 Regulatory

Bulletin from the extraordinary general meeting in PMD Device Solutions AB (publ)

October 14, 2024 Regulatory

NOTICE OF EXTRAORDINARY GENERAL MEETING IN PMD DEVICE SOLUTIONS AB (PUBL)

October 11, 2024 Regulatory

PMDS’ Largest Shareholder Requests EGM to Appoint New Non-Executive Directors Amid Management Changes

October 7, 2024 Regulatory

PMD Device Solutions Restructures to Focus Resources on Global Sales Expansion

September 26, 2024 Regulatory

NOTICE OF EXTRAORDINARY GENERAL MEETING IN PMD DEVICE SOLUTIONS AB (PUBL)

September 17, 2024 Non Regulatory

PMD Device Solutions’ RespiraSense Technology Demonstrates Capability in Predicting 7-Day Mortality

September 12, 2024 Regulatory

PMDS carries out a directed issue of shares to underwriter in the completed rights issue

September 11, 2024 Non Regulatory

PMDS Secures New Contract in the Western United States, Accelerating Path to Profitability

September 5, 2024 Non Regulatory

PMD Device Solutions Secures Significant Sales Contract, Setting the Stage for Significant Growth in the US

September 4, 2024 Regulatory

PMDS announces outcome of rights issue

August 22, 2024 Regulatory

Q2 Interim report April-June 2024

August 16, 2024 Regulatory

PMDS publishes information memorandum in connection with the forthcoming rights issue

August 15, 2024 Regulatory

PMDS preliminary P&L results ahead of Q2 Interim Report

July 5, 2024 Regulatory

PMDS carries out a rights issue of approximately SEK 27.5 million

June 28, 2024 Regulatory

Bulletin from the 2024 Annual General Meeting of PMD

June 25, 2024 Regulatory

PMD Device Solutions increases financial target with 160% to 260m SEK by YE 2026

June 13, 2024 Non Regulatory

PMDS CEO and founder Myles Murray transfers his personal shares in the company to a Swedish holding company

June 11, 2024 Regulatory

PMDS intends to carry out a rights issue of approximately SEK 27.5 million, and gives market update regarding business model

May 28, 2024 Regulatory

Q1 Interim report January-March 2024

May 27, 2024 Regulatory

PMD DEVICE SOLUTIONS AB (PUBL) POSTPONES THE ANNUAL GENERAL MEETING

May 13, 2024 Non Regulatory

PMD Device Solutions signs Letter of Intent for the Coala-Life technology for 2 MSEK per year with royalties

May 2, 2024 Non Regulatory

PMD Device Solutions agrees on head of terms to license the Coala-Life technology

April 26, 2024 Regulatory

NOTICE OF ANNUAL GENERAL MEETING IN PMD DEVICE SOLUTIONS AB (PUBL)

April 26, 2024 Regulatory

PMD Device Solutions publishes 2023 Annual report

April 11, 2024 Non Regulatory

PMD Device Solutions signs transfer agreement for key assets in Coala-Life Group AB to accelerate its US market entry

April 11, 2024 Non Regulatory

Update to closure date for the Transfer Agreement between PMD Device Solutions and Coala-Life Group AB

April 9, 2024 Regulatory

PMD Device Solutions intends to acquire key assets in Coala-Life Group AB to accelerate its US market entry

April 3, 2024 Regulatory

Bulletin from the Extraordinary General Meeting of PMD Device Solutions AB held on 3 April 2024

March 28, 2024 Non Regulatory

Rett Syndrome Research Trust selects PMD Solutions’ RespiraSense in their upcoming US-based biosensor validation study – VIBRANT.

March 25, 2024 Non Regulatory

PMD Device Solutions begins preparation for first German hospital pilot

March 15, 2024 Regulatory

NOTICE OF EXTRAORDINARY GENERAL MEETING IN PMD DEVICE SOLUTIONS AB (PUBL)

March 4, 2024 Non Regulatory

Redeye initiates coverage of PMD Device Solutions

February 29, 2024 Regulatory

Year-end report April-December 2023

January 29, 2024 Regulatory

PMD announces new ISIN code and timetable for reverse split of shares

January 25, 2024 Non Regulatory

RespiraSense selected by an industry-leading ventilation company for clinical studies.

January 25, 2024 Non Regulatory

PMD informs about the record date and procedure of reverse split of shares

January 23, 2024 Non Regulatory

PMDS share price increase

January 16, 2024 Regulatory

PMD – new name and ticker symbol; Irish Minister to attend bell-ringing ceremony

January 16, 2024 Regulatory

PMD updates on the reverse share split following the reverse acquisition

January 15, 2024 Regulatory

PMD carries out a directed share issue in order to increase the previous capital raise

December 29, 2023 Regulatory

Report from the Extraordinary General Meeting of Promore Pharma AB held on 29 December 2023

December 21, 2023 Regulatory

Promore Pharma AB (publ) has received approval for continued trading on Nasdaq First North Growth Market and publishes company description

December 8, 2023 Regulatory

Update on reverse acquisition – PMD completes private placement and major shareholder receives exemption from mandatory bid requirements

November 29, 2023 Regulatory

Correction: NOTICE OF EXTRAORDINARY GENERAL MEETING IN PROMORE PHARMA AB (PUBL)

November 29, 2023 Regulatory

NOTICE OF EXTRAORDINARY GENERAL MEETING IN PROMORE PHARMA AB (PUBL)

November 29, 2023 Regulatory

Promore Pharma AB intends to carry out a reverse acquisition of PMD Device Solutions AB